The measures addressed in this article is about coronavirus, not SARS-CoV-2 (COVID-19). With a president that favors taking bleach to fight COVID-19, I think it is important to protect people from such ideas. The mouthwash is the potential to protect from the common cold. It is still unclear about COVID-19.
There is some discussion about using baby shampoo in nasal rinses. NOT WITHOUT A DOCTOR'S ORDER.
October 20, 2020
By Rachel Grumman Bender
By Rachel Grumman Bender
Mouthwashes may help lower the transmission and spread of the coronavirus, according to a new study.
In the study, published in the Journal of Medical Virology, researchers investigated over-the-counter mouthwashes and nasal rinses commonly found in drug stores and supermarkets, since both types of products “directly impact the major sites of reception and transmission of human coronaviruses (HCoV)” — namely, the mouth and nose — and “may provide an additional level of protection against the virus.”
To find out whether mouthwashes and nasal rinses would be effective against the coronavirus, the researchers tested a common human coronavirus known as 229e — one of several strains that typically only cause mild infections like the common cold, according to the Centers for Disease Control and Prevention — not SARS‐CoV‐2, which is the virus associated with COVID‐19....
The study below is great news, it is however about one health care system and not more diverse practices. There could be many reasons for this drop in one health care system, including the fact the USA just came off a summertime when the rate of new illnesses did fall.
This study out of New York University's Grossman School of Medicine is a sign of hope. It definitely reflects an increased competency in HOSPITAL TREATMENT in a state that suffered the highest initial infection population of COVID-19 patients. A dedicated staff will find an ever-increasing better technique with more experience with the virus and patient symptomology.
Recently there were confusing reports about remdesivir (click here). The WHO found that remdesivir was not helpful. The British study was a double blind study that cannot be dismissed. In that study, it was found that when remdesivir is administered early in the infection there was a marked difference in the patient outcome. That is important and can be built on. The idea of finding infections early requires countries to increase their testing. That means the USA is not pursuing the right strategy with the SARS-CoV-2 virus.
October 20, 2020
By Geoff Blumfiel
By Geoff Blumfiel
Two new peer-reviewed studies (click here) are showing a sharp drop in mortality among hospitalized COVID-19 patients. The drop is seen in all groups, including older patients and those with underlying conditions, suggesting that physicians are getting better at helping patients survive their illness.
"We find that the death rate has gone down substantially," says Leora Horwitz, a doctor who studies population health at New York University's Grossman School of Medicine and an author on one of the studies, which looked at thousands of patients from March to August.
The study, which was of a single health system, finds that mortality has dropped among hospitalized patients by 18 percentage points since the pandemic began. Patients in the study had a 25.6% chance of dying at the start of the pandemic; they now have a 7.6% chance.
That's a big improvement, but 7.6% is still a high risk compared with other diseases, and Horwitz and other researchers caution that COVID-19 remains dangerous....
